europeanpharmaceuticalreview.com

Leveraging early insights to accelerate the oral drug development cycle

![Ramesh Muttavarapu](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Ramesh-Muttavarapu-150x150-1.jpg)

**Ramesh Muttavarapu –** **Global Subject Matter Expert – Technical and Scientific Affairs**

Ramesh Muttavarapu is a global subject matter expert on oral solids forms. He has more than 20 years of industrial experience in developing and commercialising these dosage forms. He is experienced in formulating simple to complex dosage forms including multiparticulates. His multiparticulate experience includes fluid bed coating, extrusion and spheronisation, hot melt extrusion and mini tablets with tailored drug release profiles covering immediate, delayed, controlled and pulsatile.

Ramesh has developed numerous multiparticulate products, commercialised three products, and is the co-inventor of a patent on delayed release pellets. Ramesh earned his Bachelors and Masters in pharmaceutics from the University of Bangalore and University of Annamalai, India, respectively.  Additionally, he earned an MBA from Linder College of Business, University of Cincinnati, OH, USA

**FAQs** 

**Is the panel discussion free?** 

Yes – there is no charge to watch the panel discussion, either live or on-demand. 

**When will the panel discussion take place?** 

28 May at 3pm BST.

**Can I watch it later?** 

The panel discussion will become available to watch on-demand shortly after the live webinar takes place. 

**What are the benefits of attending live?** 

You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session. 

**How long will the panel discussion be?** 

This panel discussion will last up to an hour. 

**What do I need to watch this panel discussion?** 

All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.

Read full news in source page